Peptides for Emotional Stability—not Just Mood

Peptides for Emotional Stability—not Just Mood

The Emerging Field of “Emotional Regulation Peptides” Most discussions around emotional well-being revolve around anxiolytics, neurotransmitter modifiers, or traditional mood-focused compounds. But a new research category is rising in visibility—peptides that support emotional regulation and resilience rather than simply altering mood. These compounds interact with neural circuitry, neurotrophic factors, and stress-modulation pathways in ways that

Semax & Selank vs. Their N-Acetyl Versions: Why NA Analogues Often Perform Better in Research

Semax & Selank vs. Their N-Acetyl Versions: Why NA Analogues Often Perform Better in Research

Introduction Semax and Selank are two of the most widely researched neuroactive peptides derived from tuftsin- and melanocortin-related sequences. Both are ultra-short heptapeptides that demonstrate unique interactions with neurotrophic, cognitive, and emotional-regulation pathways. In recent years, researchers have increasingly turned their attention to N-Acetyl Semax and N-Acetyl Selank—structurally modified analogues created by adding an acetyl

Peptides That Influence Circadian Rhythm Micro-Regulation

Peptides That Influence Circadian Rhythm Micro-Regulation

Introduction Most people think of sleep peptides. But almost nobody knows there are research peptides that fine-tune the cellular clock machinery itself — the CLOCK/BMAL1 gene complex, melatonin receptor density, mitochondrial timekeeping, and neuronal resilience within circadian-regulated regions of the brain. This field is called circadian micro-regulation, and it is one of the most overlooked

You were not leaving your cart just like that, right?

Your Cart Is Still Saved 👀

Don’t lose your saved cart. Enter your email below so your research items are ready whenever you return.

lIMITED tIME rESEARCH aCCESS!

20% Off

      • Use Code: WELCOME20

BioGenix Peptides

Research Use & Access
Confirmation

Before entering this website, please read and agree
to the following statement:

You are not old enough to view this content.